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Abstract 
The broth culture method is the gold standard for the diagnosis of bacterial infection, but a definitive result can 
take 24 hours or more before a conclusive diagnosis. Procalcitonin is one of the promising markers because its 
concentration is found increasing in sepsis especially in bacterial infections. The objective of this study was to 
determine the average level of procalcitonin in patients with sepsis. It was a cross sectional study. Seventeen 
(17)  patients who were admitted to the Inpatient Installation Hospital of Wahidin Sudirohusodo Makassar 
because of sepsis were enrolled into this study. Samples were affordable population that meets the study criteria 
and selected in the order of admission in the hospital (Consecutive Random Sampling). To validate the results of 
procalcitonin examination, confirmation was made with the results of the culture as the gold standard. 
Procalcitonin levels in sepsis patients was ranged from 8,29 - 188,94 ng / ml with an average value of 60,14 ± 
54,53 ng / ml. Conclusion of this study is PCT has been proposed as a pertinent marker in the rapid diagnosis of 
bacterial infection, especially for use in hospital emergency departments and intensive care units. 
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1. Introduction 
Sepsis is a clinical syndrome occurring in patients following infection or injury, is a leading cause of morbidity 
and mortality worldwide [1,2]. Sepsis refers to the systemic response to infection by microbial agents, such as 
bacteria, fungi, and yeast, where the patient typically develops fever, tachycardia, tachypnea, and leukocytosis. 
Microbiologic cultures from the blood or the infection site are frequently, although not invariably, positive [3,4]. 
The signs and symptoms of sepsis are highly variable and are influenced by many factors, including the 
virulence and bioburden of the pathogen, the portal of entry, and the host susceptibility. Distinguishing 
inflammation due to bacterial, other microbial infection, or organ rejection is important in the treatment of the 
immune reaction in hospitalized patients [5].  A common problem in the clinical practice is that the signs and 
symptoms of bacterial and viral infections are widely overlapping, especially in respiratory tract infections. The 
traditional method of diagnosis for sepsis includes culturing blood, urine, cerebrospinal fluid (CSF), or bronchial 
fluid specimens and usually takes 24 to 48 hours. Unfortunately, clinical symptoms frequently manifest 
themselves in the absence of a positive culture. To date, second to C-reactive protein, Procalcitonin has become 
the most widely used biomarker in the management of infection and sepsis in Europe and mean while has also 
become available in most parts of the world [6]. 
2. Methods 
It was a cross sectional study, the study population were all patients with sepsis who entered in the inpatient 
installation hospital of Wahidin Sudirohusodo Makassar. Sample were affordable population that meets the 
study criteria and selected in the order of admission in the hospital (Consecutive Random Sampling).The 
number of  sample were 17 patients.  Inclusion criteria were18-80 years old, treated in emergency room 
inpatient hospital, fulfilled two of SOFA Score criteria,  patients supporting with infection documentation such 
as culture and serology. Patients were not suffering from thyroid disease and haematological malignancy, and 
did not get long-term steroid therapy before study. Exclusion criteria was blood samples lysis,  lipemic or 
incomplete data.  Ethical permission was obtained from the ethics committee of Hasanuddin University medical 
faculty, study consent was from emergency and inpatient Installation Wahidin Sudirohusodo hospital of 
Makassar. Each subject gets informed consent before participating in the research. 
Data is displayed in the form of descriptive tables of sample characteristics. 
3. Resullt 
The clinical characteristics of sepsis patients are age, sex, culture results and average procalcitonin levels can be 
seen in table 1 
The results of this study showed that the average procalcitonin level of patients with sepsis was 60.14 ± 54.53 
ng / ml and  blood cultures showed 82.35% positive bacteria, 5.88% fungi and 11.77% no growth. 
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Table 1: Clincal Caracteristic of sepsis patients 
No. Variabel n = 17 (Sepsis) Range Mean ± SD 
1. Age(y)  24-80 52,71 ± 15,34 
2. Sex / Male (%) 9 (52.9)   
3. Status 
• Survived 
• Nonsurvived 
 
6 (35.3%) 
11 (64.7%) 
  
4. Culture 
• Bacteria  
1. Acinetobacter baumannii 
2. Burkholderia sp 
3. Escherichia coli 
4. Enterococcus faecalis 
5. Klebsiella pneumonia 
6. Staphylococcus sp 
• Fungi (Candida Tropicalis) 
• No Growth 
 
14 (82.35%) 
2 
3 
3 
1 
1 
4  
1  
1(5.88%) 
2 (11.77%) 
  
5. Procalcitonin  8,29 - 188,94 60,14 ±  54,53 
 
4. Discussion 
The use of procalcitonin (PCT) as a potential biomarker for sepsis and infection was first described in 1993. 
Compared to any other currently available sepsis marker, PCT seems to have some potential to discriminate 
between infectious and noninfectious systemic inflammation.  The culture results obtained in this study show 
that most of the causes of sepsis are bacteria   PCT also seems to have some potential to differentiate between 
viral and bacterial infections and may indicate the presence of bacterial superinfection in patients with viral 
diseases [7,8]. Candida-related severe sepsis or septic shock does not necessarily elicit a substantial increase in 
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serum PCT levels. A retrospective comparison of episodes of bacteremia or candidemia in nonneutropenic 
patients with sepsis showed that PCT levels were significantly lower or near normal in patients with candidemia. 
Thus, the value of PCT for the diagnosis of fungal infection and sepsis is poor [9]. The most frequently isolated 
pathogens in patients with sepsis include the gram-positive bacteria Streptococcus pneumoniae and 
Staphylococcus aureus and the gram-negative bacteria Escherichia coli, Klebsiella spp., and Pseudomonas 
aeruginosa.  In addition, fungal sepsis, mainly caused by Candida species, is on the rise, at least in part due to 
an increase in immune compromised patients. Pathogens associated with sepsis express an imposing arsenal of 
virulence factors, each of which contributes to the severity of the infectious insult [10] While sepsis can 
potentially be caused by many infectious agents such as bacteria, fungi, parasites or virus, the majority of cases 
of sepsis are reported to be due to bacteria. One European study reported that the most frequent infectious agent 
that was associated with sepsis was Escherichia coli, with 22.7% share of de tected cases. A more detailed study 
by Vincent and his colleagues surveyed the prevalence and outcomes of infection in intensive care units from 75 
countries. The results revealed that the microbiological culture results were positive in 70% of the infected 
patients with 62% of the positive isolates being gram-negative organisms, 47% be- ing gram-positive, and 19% 
being fungal in [11]. Bode-J¨anisch and his colleagues outline that, at PCT levels <2 ng/mL, bacterial sepsis or 
septic shock can almost certainly be excluded as cause of death. PCT levels ≥10 ng/mL can be detected 
occasionally in conditions other than sepsis. A final assessment should therefore take into account the PCT 
levels, autopsy results, and the histopathological and microbiological findings. Other authors indicate high 
diagnostic accuracy for both lipopolysaccharidebinding protein (LBP) and PCT, considered individually and 
combined, in detecting sepsis-related outcomes in postmortem [12] 
5. Conclusion 
Procalcitonin is a biomarker to determine the presence of sepsis quickly 
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